Adverse Drug Reactions

Drug Eruptions in Dogs: Medication-Caused Skin Reactions

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated June 2026 · 10 min read

Drug Eruptions in Dogs guide for dog owners

Key Takeaways

Drug eruptions are adverse skin reactions caused by medications, ranging from mild rashes to life-threatening conditions like toxic epidermal necrolysis (TEN).
Sulfonamide antibiotics, cephalosporins, NSAIDs, and anticonvulsants are among the most commonly implicated drug classes in dogs.
Erythema multiforme presents as target-like skin lesions and mucosal erosions, while TEN involves widespread epidermal detachment.
The most critical treatment step is immediate withdrawal of the suspected causative medication.
Supportive care including wound management, pain control, fluid therapy, and nutritional support is essential for recovery.

Every medication carries some risk of adverse effects, and the skin is one of the organs most frequently affected by drug reactions in dogs. Drug eruptions, formally known as cutaneous adverse drug reactions, encompass a wide spectrum of skin changes caused by medications administered at standard therapeutic doses. These reactions are not the same as overdose effects or expected side effects; instead, they represent unpredictable immunological or idiosyncratic responses unique to individual patients.

For veterinarians and dog owners alike, drug eruptions present a diagnostic challenge. The skin changes can mimic many other conditions, from autoimmune diseases to infectious skin disorders, and the temporal relationship between starting a medication and developing skin changes is not always obvious. Some reactions appear within hours of the first dose, while others develop only after weeks or months of seemingly uneventful therapy.

This guide provides an in-depth look at how medications cause skin reactions in dogs, which drugs are most commonly involved, how to recognize the different clinical patterns from mild fixed drug eruptions to the life-threatening toxic epidermal necrolysis, and what steps veterinarians and owners should take when a drug eruption is suspected.

How Medications Cause Skin Reactions

Drug eruptions occur through several distinct immunological and non-immunological mechanisms. Understanding these pathways helps explain why reactions are unpredictable, why they vary so widely in severity, and why a drug that has been tolerated for months can suddenly trigger a reaction.

Type I (Immediate) Hypersensitivity

Type I reactions involve IgE-mediated immune responses that occur within minutes to hours of drug administration. The drug or a metabolite of the drug acts as a hapten, binding to proteins in the body and triggering mast cell degranulation. This releases histamine and other inflammatory mediators, causing urticaria (hives), angioedema (facial swelling), and in severe cases, anaphylaxis. These reactions require prior sensitization, meaning the dog must have been previously exposed to the drug or a structurally similar compound.

Type III (Immune Complex) Reactions

Type III reactions involve the formation of drug-antibody complexes that deposit in blood vessel walls, activating complement and causing vasculitis. These reactions typically develop 7 to 21 days after starting a medication and can produce purpura, skin necrosis, and systemic signs including fever, joint swelling, and kidney inflammation. Serum sickness-like reactions fall into this category.

Type IV (Delayed) Hypersensitivity

Type IV reactions are T-cell mediated and represent the mechanism behind many of the most clinically significant drug eruptions, including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. These reactions involve cytotoxic T lymphocytes that directly attack keratinocytes (skin cells) displaying drug-modified proteins on their surface. The onset is typically delayed by days to weeks after initiating therapy.

Idiosyncratic Reactions

Some drug eruptions do not fit neatly into the standard immunological classification and are termed idiosyncratic. These may involve abnormal drug metabolism that produces toxic intermediates, genetic variations in drug-metabolizing enzymes, or poorly understood interactions between the drug and the patient's unique immune makeup. Idiosyncratic reactions are, by definition, unpredictable based on the drug's pharmacological profile.

Commonly Implicated Medications

Sulfonamide Antibiotics

Sulfonamides (trimethoprim-sulfamethoxazole, sulfadimethoxine) are among the most frequently reported causes of drug eruptions in dogs. Doberman Pinschers, Miniature Schnauzers, and Samoyeds appear to have a genetic predisposition to sulfonamide hypersensitivity. Reactions can range from mild urticaria to life-threatening toxic epidermal necrolysis and may include concurrent systemic signs such as fever, polyarthritis, blood dyscrasias, and hepatitis. The reaction typically develops within the first one to three weeks of therapy.

Cephalosporins and Penicillins

Beta-lactam antibiotics can cause a range of cutaneous reactions. Urticaria and maculopapular eruptions are the most common presentations. Cross-reactivity between penicillins and cephalosporins can occur, meaning a dog that reacted to one may also react to the other, though this is not universal.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs including carprofen, meloxicam, and deracoxib can cause cutaneous adverse reactions, though these are relatively uncommon. Fixed drug eruptions, characterized by a localized inflammatory reaction that recurs in the exact same location each time the drug is administered, have been associated with NSAIDs. More severe reactions including erythema multiforme have been occasionally reported.

Anticonvulsants

Phenobarbital, potassium bromide, and zonisamide have all been associated with cutaneous adverse reactions in dogs. Phenobarbital-associated reactions are the most frequently documented and can include superficial necrolytic dermatitis (hepatocutaneous-type skin changes secondary to drug-induced liver damage), as well as more typical drug eruption patterns.

Other Implicated Drugs

A wide range of other medications has been reported to cause drug eruptions in dogs, including griseofulvin, doxorubicin (chemotherapy), levothyroxine, and various topical products. Even medications applied to the skin surface can trigger systemic immune-mediated reactions in sensitized individuals.

Clinical Patterns of Drug Eruptions

Urticaria and Angioedema

Urticaria (hives) presents as raised, round-to-irregular wheals in the skin, sometimes with visible hair standing erect over each lesion. Angioedema involves deeper tissue swelling, most commonly affecting the face, muzzle, periorbital region, and ears. These Type I reactions develop rapidly, often within minutes to hours of drug administration, and typically resolve within 24 to 48 hours after the drug is discontinued and antihistamines are administered.

Erythema Multiforme

Erythema multiforme (EM) is a distinctive reaction pattern characterized by target-like (bull's-eye) skin lesions consisting of concentric rings of erythema, pallor, and central darkening or blistering. Lesions are often symmetric and may affect the trunk, groin, axillae, ear pinnae, and mucocutaneous junctions. Oral erosions and ulcers are common and can make eating painful. Erythema multiforme minor involves limited skin and mucosal lesions, while erythema multiforme major (also called Stevens-Johnson syndrome) features more extensive mucosal involvement and systemic illness.

Toxic Epidermal Necrolysis (TEN)

Toxic epidermal necrolysis is the most severe form of drug eruption and represents a dermatological emergency. The immune-mediated attack on keratinocytes causes widespread epidermal detachment, where large sheets of epidermis separate from the dermis, leaving raw, painful, weeping surfaces similar to a severe burn. TEN typically involves detachment of more than 30 percent of the body surface area. Mucosal surfaces (oral cavity, conjunctivae, urogenital tract) are almost always affected. Without aggressive intensive care, TEN carries a mortality rate of 30 to 50 percent or higher in dogs.

Fixed Drug Eruption

A fixed drug eruption is a localized inflammatory reaction that occurs at the same anatomic site each time the offending drug is administered. The lesion presents as a well-circumscribed area of erythema, edema, and sometimes blistering or ulceration. Between exposures, the site may show residual hyperpigmentation. Fixed drug eruptions are less common in dogs than in humans but have been documented with several drug classes.

Morbilliform Eruption

Morbilliform (measles-like) eruptions present as widespread, symmetrical, small red macules and papules that are often mildly pruritic. This is one of the most common drug eruption patterns and typically develops 7 to 14 days after starting a new medication. While usually self-limiting after drug withdrawal, morbilliform eruptions can occasionally progress to more severe patterns if the drug is continued.

Diagnosing Drug Eruptions

Diagnosing a drug eruption requires demonstrating a temporal relationship between medication administration and the onset of skin changes, ruling out other causes of the observed skin pattern, and ideally observing resolution after the drug is withdrawn.

Timeline Assessment

A detailed medication history is the most important diagnostic tool. For each current medication, document the start date, dose, any dose changes, and the temporal relationship to skin changes. Most drug eruptions develop within the first one to four weeks of initiating a new medication, though delayed reactions can occur with drugs used chronically. The diagnosis is strongly supported when skin lesions improve within days to weeks of discontinuing the suspected drug.

Skin Biopsy

Biopsy findings in drug eruptions vary by pattern. Erythema multiforme shows characteristic individual keratinocyte necrosis (apoptosis) at all levels of the epidermis, often with a lymphocyte-rich interface dermatitis. TEN shows full-thickness epidermal necrosis with minimal inflammatory infiltrate. These histopathological patterns, while suggestive, are not completely specific for drug reactions and can also occur in other immune-mediated conditions.

Rechallenge and Provocation Testing

Intentional rechallenge with a suspected drug for diagnostic confirmation is generally not recommended due to the risk of triggering a more severe reaction. However, accidental rechallenge (when a patient is inadvertently re-exposed to a drug that previously caused a reaction) provides strong evidence for causation if the same reaction recurs. Patch testing and in vitro lymphocyte transformation testing have been explored as safer diagnostic alternatives but are not widely available in veterinary medicine.

Ruling out other conditions is essential. Autoimmune diseases such as pemphigus and bullous pemphigoid can produce erosive lesions that resemble drug eruptions. Infectious causes including dermatophytosis, staphylococcal pyoderma, and viral exanthems must also be considered. A thorough diagnostic workup that includes biopsy, cultures, and immune testing helps differentiate these conditions from true drug eruptions.

Treatment and Emergency Management

Immediate Drug Withdrawal

The single most important therapeutic intervention is immediate discontinuation of the suspected causative drug. If the patient is taking multiple medications and the specific culprit is uncertain, all non-essential medications should be stopped simultaneously when feasible. Essential medications may need to be replaced with alternatives from different drug classes. In many cases, skin improvement begins within 48 to 72 hours of drug withdrawal, though complete resolution may take one to four weeks depending on the severity and pattern of the reaction.

Supportive Care for Erythema Multiforme

Dogs with erythema multiforme typically require supportive care including fluid therapy to maintain hydration, nutritional support (soft food if oral lesions make eating painful), gentle wound care for erosive lesions, and pain management. Topical antimicrobial therapy with chlorhexidine-based products helps prevent secondary infection of denuded skin surfaces. The use of immunosuppressive doses of corticosteroids in EM is debated among veterinary dermatologists, with some favoring short courses to halt the immune-mediated destruction and others preferring supportive care alone.

Intensive Care for Toxic Epidermal Necrolysis

TEN is a life-threatening emergency that requires hospitalization, ideally in an intensive care unit. Management parallels severe burn treatment: aggressive intravenous fluid therapy to replace insensible fluid losses through denuded skin, strict aseptic wound management, temperature regulation, nutritional support (often via feeding tube), pain management with opioid analgesics, and broad-spectrum antibiotic therapy to prevent sepsis from bacterial invasion through the compromised skin barrier. Human intravenous immunoglobulin (hIVIG) has been used in some veterinary cases with reported benefit, though evidence remains limited.

Treating Secondary Infections

The loss of epidermal barrier function in moderate to severe drug eruptions creates a high risk for secondary bacterial infection. Staphylococcus and Pseudomonas species are the most common opportunistic invaders. Topical antiseptic therapy, careful wound cleaning, and culture-guided systemic antibiotics form the foundation of infection management. Monitoring for signs of systemic infection (sepsis) is critical in hospitalized patients.

Recovery and Follow-Up

Most dogs with mild to moderate drug eruptions recover fully within two to four weeks of drug withdrawal with appropriate supportive care. Dogs surviving TEN may have a prolonged recovery period with ongoing wound care needs. All patients should have the offending drug class documented in their permanent medical record to prevent future accidental re-exposure. Owners should be educated about the importance of disclosing the drug reaction to any new veterinary provider.

Prevention and Risk Reduction

While drug eruptions cannot be entirely prevented, certain strategies can reduce the risk and minimize the impact when reactions do occur.

Breed-Specific Awareness

For breeds known to have increased susceptibility to certain drug classes, such as Doberman Pinschers and sulfonamides, veterinarians should consider alternative medications when safe and effective options exist. When the use of a high-risk drug class is clinically necessary, owners should be informed of the potential for adverse reactions and instructed to monitor for early signs.

Monitoring During New Medications

Owners should be advised to watch for skin changes, especially during the first one to four weeks after starting any new medication. Early signs to watch for include new rashes, hives, facial swelling, redness of the skin inside the ears or on the abdomen, oral sores, or generalized itchiness. Prompt reporting of these signs allows early drug withdrawal before the reaction can progress.

Maintaining a complete, updated medication history for every patient is fundamental to preventing re-exposure to drugs that have caused previous reactions. In multi-veterinarian practices and emergency settings, clear documentation in the patient's medical record, ideally flagged with an allergy alert, is essential. Owners should also keep their own record of drug reactions to share with any veterinary provider who treats their pet.

Protecting compromised skin from infection?

When drug eruptions disrupt the skin barrier, secondary bacterial infections become a serious risk. Gentle topical antimicrobial therapy helps protect denuded skin surfaces while healing progresses. Our Chlorhexidine Spray is FDA-registered, vet-formulated, and safe for use on sensitive, healing skin.

Shop Chlorhexidine Spray

Drug Eruptions in Dogs FAQ

Q: What medications most commonly cause drug eruptions in dogs?

Sulfonamide antibiotics (trimethoprim-sulfamethoxazole) are the most frequently reported cause of drug eruptions in dogs, followed by cephalosporins, penicillins, NSAIDs (carprofen, meloxicam), and anticonvulsants (phenobarbital). Doberman Pinschers, Miniature Schnauzers, and Samoyeds appear to have genetic predispositions to sulfonamide reactions. Any medication can potentially cause a skin reaction in susceptible individuals.

Q: How quickly do drug eruptions appear after starting a medication?

The timing varies by reaction type. Urticaria and angioedema (Type I reactions) can appear within minutes to hours. Morbilliform eruptions and erythema multiforme typically develop 7 to 21 days after starting a new medication. Some reactions, particularly to drugs used chronically, may not appear for weeks or months. Fixed drug eruptions recur within hours of re-exposure to a previously sensitizing drug.

Q: What is the difference between erythema multiforme and toxic epidermal necrolysis?

Erythema multiforme (EM) involves localized areas of keratinocyte death producing target-like lesions and mucosal erosions, with less than 10 percent of body surface area affected. Toxic epidermal necrolysis (TEN) represents massive, widespread epidermal death involving more than 30 percent of body surface area, with sheets of skin separating and sloughing. Stevens-Johnson syndrome falls between these two extremes. TEN is a life-threatening emergency with a significantly higher mortality rate than EM.

Q: Can a dog that had a drug reaction ever take that medication again?

No. A dog that has experienced a confirmed drug eruption should never be re-exposed to the causative drug. Re-exposure can trigger the same or a more severe reaction, potentially including life-threatening anaphylaxis or TEN. The drug class should be permanently noted in the patient's medical record. Cross-reactivity with structurally related drugs is possible, so alternative drug classes are preferred when treatment is needed.

Q: What should I do if I think my dog is having a drug reaction?

If you notice new skin changes, hives, facial swelling, oral sores, lethargy, or any unusual symptoms after starting or changing a medication, contact your veterinarian immediately. Do not stop prescribed medications on your own without veterinary guidance, unless the reaction appears severe (widespread skin changes, difficulty breathing, collapse), in which case seek emergency veterinary care. Early drug withdrawal is the most important factor in limiting the severity of a drug eruption.

Sources

Scott DW, Miller WH. Cutaneous drug reactions in dogs: an evaluation based on reported cases. Canine Practice. 1999;24(3):16-21.

Noli C, Kowalski RL, Ghibaudo G. Cutaneous adverse drug reactions in dogs: a retrospective study of 90 cases. Veterinary Dermatology. 2020;31(6):460-e123.

Hinn AC, Olivry T, Luther PB, et al. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in the dog: clinical classification, drug exposure, and histopathological correlations. Veterinary Allergy and Clinical Immunology. 1998;6(1):13-20.

Bloom PB. Canine and feline erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Campbell KL, ed. Veterinary Dermatology. Ithaca: International Veterinary Information Service; 2006.

Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. Journal of Veterinary Pharmacology and Therapeutics. 2004;27(3):129-138.